NL-OMON29047尚未招募不适用
PREVENTION OF THE PROGRESSION OF VERY EARLY SYMPTOMSINTO ANKYLOSING SPONDYLITIS:A PLACEBO CONTROLLED TRIAL WITH ETANERCEPT.
investigator drive study supported by Wyeth0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients to be included must meet the following criteria:
- •1. Age between 18-45 years, both male and female;
排除标准
- •Specific medical exclusion criteria:
- •1. Definite AS (modified New York criteria (9));
研究者
相似试验
进行中（未招募）
不适用
PREVENTION OF THE PROGRESSION OF VERY EARLY SYMPTOMSINTO ANKYLOSING SPONDYLITIS: A PLACEBO CONTROLLED TRIAL WITH ETANERCEPT - PREVASEUCTR2009-015515-40-NLWyeth Pharmaceuticals B.V.80
已完成
2 期
Prevention of the progression of very early symptoms into ankylosing spondylitisankylosing spondylitis10023213spondyloarthritisNL-OMON36697Vrije Universiteit Medisch Centrum80
已完成
不适用
Prodromal symptoms and early intervention to prevent a relapseSchizophreniaISRCTN17350364Mental Health Care Services Drenthe (Netherlands)147
招募中
不适用
Pre-frail New efforts to prevent the progression of frail by intervention of agarooligosaccharides in the elderlyfrailJPRN-UMIN000046285Matsumoo university30
尚未招募
不适用
utrition Intervention In Metabolic Syndrome In Young People With Mental Illness (NIMSMI)ObesityBipolar DisorderACTRN12617000461392Western Sydney Local Health District120